Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | VHL | P40337 | 1/20 | 0.50 |
| ▸ | ELOC | Q15369 | 1/20 | 0.50 |
| ▸ | ELOB | Q15370 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4919323 | 0.79 | MAPT (0.56) | MEN1KMT2AMAPTNPC1ALDH1A1 | |
| SCHEMBL11625350 | 0.77 | KMT2A (0.53) | NOTUMPOLBNPSR1MEN1KMT2A | |
| SCHEMBL44284 | 0.73 | KDM4E (0.50) | POLBVHLELOCELOBKDM4E | |
| SCHEMBL636960 | 0.72 | VHL (0.50) | POLBVHLELOCELOBKDM4E | |
| SCHEMBL296099 | 0.72 | MAPT (0.56) | POLBVHLELOCELOBKDM4E | |
| SCHEMBL599252 | 0.72 | VHL (0.56) | POLBVHLELOCELOBKDM4E | |
| SCHEMBL11822364 | 0.72 | KDM4E (0.50) | POLBVHLELOCELOBKDM4E | |
| SCHEMBL393880 | 0.72 | KDM4E (0.50) | POLBVHLELOCELOBKDM4E | |
| SCHEMBL5547132 | 0.72 | KDM4E (0.50) | POLBVHLELOCELOBKDM4E | |
| SCHEMBL1260035 | 0.72 | KDM4E (0.50) | POLBVHLELOCELOBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110105287-A | A kind of synthesis technology of pyraclostrobin | 江苏禾本生化有限公司 | 2019-08-09 | — | — | CN | claimed |
| CN-1232520-C | Salts of bicyclic N-acylated imidazol-3-amines and imidazol-5-amines | GRUENENTHAL GMBH (DE) | 2005-12-21 | — | — | CN | claimed |
| CN-1211385-C | Bicyclic imidazo-5-yl-amine derivs. | GRUENENTHAL GMBH (DE) | 2005-07-20 | — | — | CN | claimed |
| CN-1422270-A | Salts of bicyclic N-acylated imidazol-3-amines and imidazol-5-amines | GRUELENTHAL GMBH (DE) | 2003-06-04 | — | — | CN | claimed |
| JP-2003511456-A | — | — | 2003-03-25 | — | — | JP | claimed |
| CN-1402726-A | Bicyclic imidazo-5-yl-amine derivs. | GRUENENTHAL GMBH (DE) | 2003-03-12 | — | — | CN | claimed |
| EP-1218383-A2 | BICYCLIC IMIDAZO-5-YL-AMINE DERIVATIVES | Grünenthal GmbH (DE) | 2002-07-03 | — | — | EP | claimed |
| WO-2001027118-A2 | BICYCLIC IMIDAZO-5-YL-AMINE DERIVATIVES | Grünenthal GmbH (DE) | 2001-04-19 | — | — | WO | claimed |
| US-20250312367-A1 | OLIGONUCLEOTIDES HAVING A SYNTHETIC BACKBONE AND SYNTHESIS THEREOF | ADARX PHARMACEUTICALS, INC. (US) | 2025-10-09 | — | — | US | disclosed |
| US-12391781-B2 | Black particles, black coating material, coating film, and black matrix for color filters | SEKISUI CHEMICAL CO., LTD. (JP) | 2025-08-19 | — | — | US | disclosed |
| EP-4063426-B1 | BLACK PARTICLES, BLACK COATING MATERIAL, COATING FILM, AND BLACK MATRIX FOR COLOR FILTERS | SEKISUI CHEMICAL CO LTD (JP) | 2025-06-18 | — | — | EP | disclosed |
| WO-2025073702-A1 | PROCESS FOR PREPARING AROMATIC AMINES FROM ARYL CHLORIDES | BASF SE (DE) | 2025-04-10 | — | — | WO | disclosed |
| EP-4522628-A2 | OLIGONUCLEOTIDES HAVING A SYNTHETIC BACKBONE AND SYNTHESIS THEREOF | Adarx Pharmaceuticals, Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| CN-119485936-A | Flame-retardant flexible circuit board and preparation method thereof | 德兴市恒海科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-1187326-C | Novel compounds | ASTRAZENECA AB (SE) | 2005-02-02 | — | — | CN | disclosed |
| CN-1426393-A | Novel compounds | ASTRAZENECA AB (SE) | 2003-06-25 | — | — | CN | disclosed |
| CN-1426412-A | Novel compounds | ASTRAZENECA AB (SE) | 2003-06-25 | — | — | CN | disclosed |
| CN-1426394-A | Novel compounds | ASTRAZENECA AB (SE) | 2003-06-25 | — | — | CN | disclosed |
| CN-1422270-A | Salts of bicyclic N-acylated imidazol-3-amines and imidazol-5-amines | GRUELENTHAL GMBH (DE) | 2003-06-04 | — | — | CN | disclosed |
| CN-1402726-A | Bicyclic imidazo-5-yl-amine derivs. | GRUENENTHAL GMBH (DE) | 2003-03-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250312367-A1 | OLIGONUCLEOTIDES HAVING A SYNTHETIC BACKBONE AND SYNTHESIS THEREOF | POLRMT, TARDBP, NSUN2 | NOTUM 4490/4885POLB 20/4885VHL 842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.